Moderna completed construction of its mRNA vaccine production facility in Laval, Quebec. It has received a Drug Establishment License from Health Canada to produce medicines. Its goal is to domestically manufacture a portfolio of mRNA vaccines — COVID-19, RSV, seasonal flu — starting in 2025.
5 months ago